EPO and diabetic kidney disease: The correlations between CD74, AKR1B1, and EPO suggest that CD74 may modulate both oxidative stress pathways (AKR1B1) and erythropoiesis (EPO), indicating its dual role in pro-inflammatory and protective mechanisms within DKD.